Covid-19

Fuelled by innovation, the outlook for the biotech sector remains positive and should be viewed separately from the macro environment, says Peter Hughes.

Biggest risk of 2022

0.5pp hike on the table

Trading at a discount of 9.8%

Robust dividends

The latest ‘supertrends’ report from Credit Suisse shows concern for the Covid-19 pandemic has reduced while economic worries remain high, including in the basic affordability of necessities.

Golden opportunities post pandemic

Five key themes to dominate next 12 months

Reason for optimism

Investors are getting younger and more vocal